Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| CD8-M82E3 | Mouse | Biotinylated Mouse CD28 Protein, His,Avitag™, active dimer (MALS verified) |  |
|
|
| CD8-H82E5 | Human / Cynomolgus / Rhesus macaque | Biotinylated Human / Cynomolgus / Rhesus macaque CD28 Protein, His,Avitag™, active dimer (MALS verified) |  |
|
|
| CD8-H52Hc | Human / Cynomolgus / Rhesus macaque | Human / Cynomolgus / Rhesus macaque CD28 Protein, His Tag, active dimer (MALS verified) |  |
|
|
| CD8-H525a | Human / Cynomolgus / Rhesus macaque | Human / Cynomolgus / Rhesus macaque CD28 Protein, Fc Tag, active dimer (MALS verified) |  |
|
|
| CD8-H52A5 | Human / Cynomolgus / Rhesus macaque | Human / Cynomolgus / Rhesus macaque CD28 Protein, Mouse IgG2a Fc Tag (MALS verified) |  |
|
|
| CD8-H82F2 | Human / Cynomolgus / Rhesus macaque | Biotinylated Human / Cynomolgus / Rhesus macaque CD28 Protein, Fc,Avitag™, active dimer (MALS verified) |  |
|
|
| CD8-M5257 | Mouse | Mouse CD28 Protein, Fc Tag |  |
|
|
| CD8-M52H6 | Mouse | Mouse CD28 Protein, His Tag, active dimer (MALS verified) |  |
|
|
Immobilized Human / Cynomolgus / Rhesus macaque CD28, Fc Tag (Cat. No. CD8-H525a) on CM5 Chip can bind Human B7-1, His Tag (Cat. No. B71-H5228) with an affinity constant of 5.29 μM as determined in a SPR assay (Biacore T200) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Membrane bound ligand T-SIGn virus | NG-348 | Phase 1 Clinical | Psioxus Therapeutics | Neoplasms | Details |
| FR-104 | FR-104; JNJ-3133 | Phase 2 Clinical | Effimune | Arthritis, Rheumatoid; Rejection of organ transplantation; Postoperative Complications | Details |
| Theralizumab | TAB-08; TABO-8 | Phase 2 Clinical | Theramab | Carcinoma, Merkel Cell; Arthritis, Rheumatoid; Lupus Erythematosus, Systemic; Psoriasis | Details |
| B7-2/GM-CSF cancer gene therapy | CIT | Phase 1 Clinical | Radient | Neoplasms | Details |
| FPT-155 | CD80-Fc; FPT-155 | Phase 1 Clinical | Five Prime Therapeutics | Neoplasms | Details |
| Abatacept (Orban Biotech) | Phase 2 Clinical | Orban Biotech, The National Institute Of Diabetes And Digestive And Kidney Diseases | Diabetes Mellitus, Type 1 | Details | |
| Lulizumab pegol | Lulizumab; BMS-931699 | Phase 2 Clinical | Bristol-Myers Squibb Company | Lupus Vulgaris; Sjogren's Syndrome; Lupus Erythematosus, Systemic; Sjogren-Larsson Syndrome | Details |
| Reltecimod | P2-TA; AB-103 | Phase 3 Clinical | Atox Bio | Peritonitis; Acute Kidney Injury; Fournier Gangrene; Fasciitis, Necrotizing; Soft Tissue Infections | Details |
| CD19 PD-1/CD28 CAR-T Cell Therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine) | Phase 1 Clinical | Lymphoma, B-Cell | Details | ||
| ALPN-101 | ALPN-101 | Phase 2 Clinical | Alpine Immune Sciences | Graft vs Host Disease; Autoimmune Diseases; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Inflammation | Details |
| ALPN-202 | ALPN-202 | Phase 1 Clinical | Alpine Immune Sciences | Solid tumours; Lymphoma | Details |
| Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells (City of Hope Medical Center) | Phase 1 Clinical | City Of Hope National Medical Center | Lymphoma, Non-Hodgkin | Details |
This web search service is supported by Google Inc.
A-Z